12
FV & Narrative | Valuation | Growth | Analyst Target | |||
|---|---|---|---|---|---|---|
CW Curtiss-Wright US$570.04n/aintrinsic discount 0.8%7D -26.2%3M The author hasn't set a fair value for CW | ||||||
GIVN Givaudan CHF 3,244.00n/aintrinsic discount 1.5%7D 1.6%3M The author hasn't set a fair value for GIVN | ||||||
GAW Games Workshop Group UK£177.20n/aintrinsic discount 0.9%7D -14.0%3M The author hasn't set a fair value for GAW | ||||||
SPGI S&P Global US$406.76n/aintrinsic discount -2.8%7D -1.0%3M The author hasn't set a fair value for SPGI | ||||||
RMS Hermès International Société en commandite par actions €1,383.00n/aintrinsic discount -1.8%7D -21.6%3M The author hasn't set a fair value for RMS | ||||||
SPX Spirax Group UK£68.55n/aintrinsic discount -2.1%7D -3.6%3M The author hasn't set a fair value for SPX | ||||||
AMZN Amazon.com US$245.96n/aintrinsic discount -2.4%7D 0.6%3M The author hasn't set a fair value for AMZN |
12
FV & Narrative | Valuation | Growth | Analyst Target | |||
|---|---|---|---|---|---|---|
CPU Computershare 3.3%7D 9.1%3M | AU$40.53 n/aintrinsic discount | The author hasn't set a fair value for CPU | PE 27x | E 9.0% | AU$39.43 | |
CW Curtiss-Wright 0.8%7D -26.2%3M | US$570.04 n/aintrinsic discount | The author hasn't set a fair value for CW | PE 38.9x | E 9.7% | US$786.25 | |
GIVN Givaudan 1.5%7D 1.6%3M | CHF 3,244.00 n/aintrinsic discount | The author hasn't set a fair value for GIVN | PE 31.4x | E 9.1% | CHF 3,434.56 | |
DPLM Diploma 1.2%7D 0.5%3M | UK£71.70 n/aintrinsic discount | The author hasn't set a fair value for DPLM | PE 50.8x | E 14.6% | UK£82.54 | |
RACE Ferrari 2.5%7D 13.9%3M | US$412.34 n/aintrinsic discount | The author hasn't set a fair value for RACE | PE 42x | E 7.3% | US$448.66 | |
GAW Games Workshop Group 0.9%7D -14.0%3M | UK£177.20 n/aintrinsic discount | The author hasn't set a fair value for GAW | PE 28.4x | E 1.8% | UK£220.75 | |
MA Mastercard 0.04%7D 15.9%3M | US$567.75 n/aintrinsic discount | The author hasn't set a fair value for MA | PE 30.6x | E 11.2% | US$666.71 | |
CME CME Group -0.8%7D 10.6%3M | US$272.46 n/aintrinsic discount | The author hasn't set a fair value for CME | PE 23x | E 3.4% | US$283.60 | |
SPGI S&P Global -2.8%7D -1.0%3M | US$406.76 n/aintrinsic discount | The author hasn't set a fair value for SPGI | PE 24.4x | E 7.3% | US$520.30 | |
RMS Hermès International Société en commandite par actions -1.8%7D -21.6%3M | €1,383.00 n/aintrinsic discount | The author hasn't set a fair value for RMS | PE 32.1x | E 10.6% | €1,835.27 | |
SPX Spirax Group -2.1%7D -3.6%3M | UK£68.55 n/aintrinsic discount | The author hasn't set a fair value for SPX | PE 25.5x | E 11.3% | UK£81.77 | |
AMZN Amazon.com -2.4%7D 0.6%3M | US$245.96 n/aintrinsic discount | The author hasn't set a fair value for AMZN | PE 19.6x | E 6.0% | US$328.22 |